mRNA MANIA: Bio-Pharmaceutical Complex Convenes to Advance Global Genetic Manipulation Agenda
Inside the 2025 Global Vaccine Forum, where microneedle patch “vaccines,” replicons, and AI-engineered injections took center stage—and plans to accelerate mRNA worldwide were unveiled.
On June 19, 2025, over 180 global operatives of the Bio-Pharmaceutical Complex gathered in Seoul for the 2025 IVI Global Vaccine Forum to discuss “Present and Future of mRNA and Other Vaccine Platform Technologies.” The primary topics included self-amplifying replicon mRNA injections, microneedle patch “vaccines”, AI-engineered genetic injections, and the race to accelerate mRNA development.
Sponsored by EuBiologics, co-hosted by the International Vaccine Institute (IVI) and Korea’s CDC (KDCA), the forum consisted of pandemic profiteers, gene therapy peddlers, and global health bureaucrats. Below is a session-by-session breakdown of what they’re planning next:
Opening Session: The Indoctrination Begins
Speakers: Dr. Dokeun Kim, Director General of the Center for Vaccine Research at the Korea National Institute of Health under KDCA and Dr. Sanjay Singh, CEO of Gennova Biopharmaceuticals
- Set the tone: “mRNA is the future” — not just for pandemics, but for everything (autoimmune disease, cancer, etc.).
- Sanjay Singh heavily promoted the extremely dangerous self-amplifying mRNA (saRNA) replicon platform.
Session 1: CEPI’s mRNA Domination Plan
Speakers: Dr. Martina Ochs, Project Leader of the mRNA Program at the Coalition for Epidemic Preparedness Innovations (CEPI) and Prof. Dan Barouch, William Bosworth Castle Professor of Medicine at Harvard Medical School,
- CEPI’s Martina Ochs revealed plans to use mRNA to “prepare” for future outbreaks — i.e., pre-authorized genetic vaccines waiting for the next declared emergency. Emphasized “the need for speed” when developing mRNA shots.
- Harvard’s Dan Barouch falsely claimed COVID-19 vaccines “saved 20 million lives in 2021”, then pitched correlates of protection to fine-tune future mRNA updates for respiratory viruses — including potential for routine intranasal or seasonal gene injections.
Session 2: AI-Engineered Vaccines + Mobile Factories
Speakers: Dr. Robert Paris, Vice President and Therapeutic Area Head at Moderna, Prof. Minkyung Baek of Seoul National University, and Dr. Sang Hwan Seo, Director at IVI
- AI-designed vaccines — merging artificial intelligence with synthetic biology to design shots in days, not years.
- Moderna’s Robert Paris pushed expanding mRNA to chronic diseases — another mass market expansion.
- Mobile mRNA manufacturing (“DeCAFx”) projects presented as “decentralization” — but really a global template for on-demand gene shot production in every region.
Session 3: Microneedle Patches & Self-Amplifying RNA
Speakers: Prof. Gerald McInerney of Karolinska Institutet, Dr. Hae-Jin Hu, Research Director at QuadMedicine, and Prof. Hyukjin Lee of Seoul National University
- Self-Amplifying RNA (saRNA) hailed as more efficient.
- Microneedle Array Patch (MAP) promoted as a pain-free, “equity-friendly” vaccine — but it’s a step toward unmonitored home gene therapy, bypassing medical supervision. The Gates Foundation has funded a method to implant permanent quantum dots to verify vaccination status using MAP technology.
- New lipid nanoparticles presented as ways to penetrate more tissues, more efficiently. What’s not said: easier penetration also means greater biodistribution — including to the brain and reproductive organs.
Session 4: Korea’s Race to Mass-Produce mRNA
Speakers: Prof. Jae-Hwan Nam, CEO of SML Biopharm, Dr. Younchul Shin, Head of Development at GC Biopharma, and Dr. Yongwook Park, Senior Vice President at SK bioscience
- Panel of biotech execs discussing mass production, public-private partnerships, and pandemic-scale rollout models.
The Agenda Is Clear
This was a global coordination meeting for the normalization of genetic manipulation, organized by the very agencies and corporations that profited off COVID-19. As expected, there was NO discussion of the immense dangers of mRNA technology, despite over 700 peer-reviewed studies revealing their serious biological risks.
They want:
- AI-designed, rapidly authorized, untested gene therapies.
- SaRNA and MAPs to enable silent, repeated delivery.
- Mobile factories ready to launch the next round on command.
- Permanent infrastructure for population-wide genetic modulation.
You can watch the full Bio-Pharmaceutical Complex meeting here: